Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1996 Oct;149(4):1105–1110.

CD79 alpha expression in acute myeloid leukemia. High frequency of expression in acute promyelocytic leukemia.

D A Arber 1, K A Jenkins 1, M L Slovak 1
PMCID: PMC1865171  PMID: 8863659

Abstract

CD79 alpha is a subunit of an intracytoplasmic protein reported to be specific for B lymphocytes, including immature B lineage cells. To evaluate expression of the CD79 alpha antigen in acute myeloid leukemia (AML), we studied forty-eight cases of AML by paraffin section immunohistochemistry. The cases included four MO, nine M1, nine M2, ten M3, ten M4, and six M5 AMLs using criteria of the French-American-British cooperative group. Eleven cases demonstrated cytoplasmic staining for the CD79 alpha antigen, including one M1, nine M3, and one M5 AML. These CD79 alpha-positive cases represented 5% of all non-promyelocytic AMLs and 90% of all acute promyelocytic leukemias studied. All acute promyelocytic leukemias had the characteristic t(15;17)(q24;q21), including two cases of the microgranular variant (M3v). No other B-lineage-associated antigens were found in the CD79 alpha-positive cases, with the exception of a subpopulation of CD19-positive leukemic cells in one patient. The two non-promyelocytic leukemias that expressed CD79 alpha had no evidence of t(15;17) and did not express any additional B-lineage-associated antigens that might suggest a mixed lineage proliferation. This study demonstrates that CD79 alpha expression in acute leukemia is not restricted to B-lineage acute lymphoblastic leukemias and that CD79 alpha expression is frequently associated with t(15;17) acute myeloid leukemia.

Full text

PDF
1106

Images in this article

1107Figure 1
on p.1107

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adriaansen H. J., te Boekhorst P. A., Hagemeijer A. M., van der Schoot C. E., Delwel H. R., van Dongen J. J. Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression. Blood. 1993 Jun 1;81(11):3043–3051. [PubMed] [Google Scholar]
  2. Alcalay M., Zangrilli D., Fagioli M., Pandolfi P. P., Mencarelli A., Lo Coco F., Biondi A., Grignani F., Pelicci P. G. Expression pattern of the RAR alpha-PML fusion gene in acute promyelocytic leukemia. Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):4840–4844. doi: 10.1073/pnas.89.11.4840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO) Br J Haematol. 1991 Jul;78(3):325–329. doi: 10.1111/j.1365-2141.1991.tb04444.x. [DOI] [PubMed] [Google Scholar]
  4. Brouns G. S., de Vries E., van Noesel C. J., Mason D. Y., van Lier R. A., Borst J. The structure of the mu/pseudo light chain complex on human pre-B cells is consistent with a function in signal transduction. Eur J Immunol. 1993 May;23(5):1088–1097. doi: 10.1002/eji.1830230517. [DOI] [PubMed] [Google Scholar]
  5. Buccheri V., Mihaljević B., Matutes E., Dyer M. J., Mason D. Y., Catovsky D. mb-1: a new marker for B-lineage lymphoblastic leukemia. Blood. 1993 Aug 1;82(3):853–857. [PubMed] [Google Scholar]
  6. Chang K. S., Stass S. A., Chu D. T., Deaven L. L., Trujillo J. M., Freireich E. J. Characterization of a fusion cDNA (RARA/myl) transcribed from the t(15;17) translocation breakpoint in acute promyelocytic leukemia. Mol Cell Biol. 1992 Feb;12(2):800–810. doi: 10.1128/mcb.12.2.800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Claxton D. F., Reading C. L., Nagarajan L., Tsujimoto Y., Andersson B. S., Estey E., Cork A., Huh Y. O., Trujillo J., Deisseroth A. B. Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia. Blood. 1992 Aug 1;80(3):582–586. [PubMed] [Google Scholar]
  8. Grignani F., Fagioli M., Alcalay M., Longo L., Pandolfi P. P., Donti E., Biondi A., Lo Coco F., Grignani F., Pelicci P. G. Acute promyelocytic leukemia: from genetics to treatment. Blood. 1994 Jan 1;83(1):10–25. [PubMed] [Google Scholar]
  9. Hiorns L. R., Min T., Swansbury G. J., Zelent A., Dyer M. J., Catovsky D. Interstitial insertion of retinoic acid receptor-alpha gene in acute promyelocytic leukemia with normal chromosomes 15 and 17. Blood. 1994 May 15;83(10):2946–2951. [PubMed] [Google Scholar]
  10. Kita K., Miwa H., Nakase K., Kawakami K., Kobayashi T., Shirakawa S., Tanaka I., Ohta C., Tsutani H., Oguma S. Clinical importance of CD7 expression in acute myelocytic leukemia. The Japan Cooperative Group of Leukemia/Lymphoma. Blood. 1993 May 1;81(9):2399–2405. [PubMed] [Google Scholar]
  11. Kita K., Nakase K., Miwa H., Masuya M., Nishii K., Morita N., Takakura N., Otsuji A., Shirakawa S., Ueda T. Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood. 1992 Jul 15;80(2):470–477. [PubMed] [Google Scholar]
  12. Lafage-Pochitaloff M., Alcalay M., Brunel V., Longo L., Sainty D., Simonetti J., Birg F., Pelicci P. G. Acute promyelocytic leukemia cases with nonreciprocal PML/RARa or RARa/PML fusion genes. Blood. 1995 Mar 1;85(5):1169–1174. [PubMed] [Google Scholar]
  13. Lithotripsy. Health and Public Policy Committee, American College of Physicians. Ann Intern Med. 1985 Oct;103(4):626–629. [PubMed] [Google Scholar]
  14. Mason D. Y., Cordell J. L., Brown M. H., Borst J., Jones M., Pulford K., Jaffe E., Ralfkiaer E., Dallenbach F., Stein H. CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples. Blood. 1995 Aug 15;86(4):1453–1459. [PubMed] [Google Scholar]
  15. Mason D. Y., Cordell J. L., Tse A. G., van Dongen J. J., van Noesel C. J., Micklem K., Pulford K. A., Valensi F., Comans-Bitter W. M., Borst J. The IgM-associated protein mb-1 as a marker of normal and neoplastic B cells. J Immunol. 1991 Dec 1;147(11):2474–2482. [PubMed] [Google Scholar]
  16. Mason D. Y., van Noesel C. J., Cordell J. L., Comans-Bitter W. M., Micklem K., Tse A. G., van Lier R. A., van Dongen J. J. The B29 and mb-1 polypeptides are differentially expressed during human B cell differentiation. Eur J Immunol. 1992 Oct;22(10):2753–2756. doi: 10.1002/eji.1830221044. [DOI] [PubMed] [Google Scholar]
  17. Paietta E., Andersen J., Gallagher R., Bennett J., Yunis J., Cassileth P., Rowe J., Wiernik P. H. The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study. Leukemia. 1994 Jul;8(7):1108–1112. [PubMed] [Google Scholar]
  18. Paietta E., Wiernik P. H., Andersen J., Bennett J., Yunis J. Acute myeloid leukemia M4 with inv(16) (p13q22) exhibits a specific immunophenotype with CD2 expression. Blood. 1993 Oct 15;82(8):2595–2595. [PubMed] [Google Scholar]
  19. Reading C. L., Estey E. H., Huh Y. O., Claxton D. F., Sanchez G., Terstappen L. W., O'Brien M. C., Baron S., Deisseroth A. B. Expression of unusual immunophenotype combinations in acute myelogenous leukemia. Blood. 1993 Jun 1;81(11):3083–3090. [PubMed] [Google Scholar]
  20. Rovelli A., Biondi A., Cantù Rajnoldi A., Conter V., Giudici G., Jankovic M., Locasciulli A., Rizzari C., Romitti L., Rossi M. R. Microgranular variant of acute promyelocytic leukemia in children. J Clin Oncol. 1992 Sep;10(9):1413–1418. doi: 10.1200/JCO.1992.10.9.1413. [DOI] [PubMed] [Google Scholar]
  21. Sakaguchi N., Kashiwamura S., Kimoto M., Thalmann P., Melchers F. B lymphocyte lineage-restricted expression of mb-1, a gene with CD3-like structural properties. EMBO J. 1988 Nov;7(11):3457–3464. doi: 10.1002/j.1460-2075.1988.tb03220.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sheibani K., Tubbs R. R. Enzyme immunohistochemistry: technical aspects. Semin Diagn Pathol. 1984 Nov;1(4):235–250. [PubMed] [Google Scholar]
  23. Van Noesel C. J., Borst J., De Vries E. F., Van Lier R. A. Identification of two distinct phosphoproteins as components of the human B cell antigen receptor complex. Eur J Immunol. 1990 Dec;20(12):2789–2793. doi: 10.1002/eji.1830201238. [DOI] [PubMed] [Google Scholar]
  24. Van Noesel C. J., Brouns G. S., van Schijndel G. M., Bende R. J., Mason D. Y., Borst J., van Lier R. A. Comparison of human B cell antigen receptor complexes: membrane-expressed forms of immunoglobulin (Ig)M, IgD, and IgG are associated with structurally related heterodimers. J Exp Med. 1992 Jun 1;175(6):1511–1519. doi: 10.1084/jem.175.6.1511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Verschuren M. C., Comans-Bitter W. M., Kapteijn C. A., Mason D. Y., Brouns G. S., Borst J., Drexler H. G., van Dongen J. J. Transcription and protein expression of mb-1 and B29 genes in human hematopoietic malignancies and cell lines. Leukemia. 1993 Dec;7(12):1939–1947. [PubMed] [Google Scholar]
  26. Yu L. M., Chang T. W. Human mb-1 gene: complete cDNA sequence and its expression in B cells bearing membrane Ig of various isotypes. J Immunol. 1992 Jan 15;148(2):633–637. [PubMed] [Google Scholar]
  27. Zutter M. M., Martin P. J., Hanke D., Kidd P. G. CD7+ acute non-lymphocytic leukemia: evidence for an early multipotential progenitor. Leuk Res. 1990;14(1):23–26. doi: 10.1016/0145-2126(90)90142-v. [DOI] [PubMed] [Google Scholar]
  28. van Noesel C. J., van Lier R. A., Cordell J. L., Tse A. G., van Schijndel G. M., de Vries E. F., Mason D. Y., Borst J. The membrane IgM-associated heterodimer on human B cells is a newly defined B cell antigen that contains the protein product of the mb-1 gene. J Immunol. 1991 Jun 1;146(11):3881–3888. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES